The development of mRNA vaccines, gene-editing therapies, and RNA interference (RNAi) medicines has created new opportunities in modern drug development. At the same time, researchers have encountered a practical challenge that goes beyond nucleic acid sequence design: how to deliver these fragile molecules efficiently and consistently to the right biological environment. Naked RNA is highly...